Anticoagulants [phsu]
Heparin [bacs, carb, phsu]
Heparin, Low-Molecular-Weight [carb, phsu]
Oral [spco]
Anticoagulants [phsu]
Intermittent Claudication [dsyn]
Background [cnce]
Anticoagulant [phsu]
treatment [ftcn]
Intermittent Claudication [dsyn]
functional capacity [topp]
PREVENT [phsu]
acute [tmco]
cardiovascular complications [patf]
peripheral arterial disease [dsyn]
This [euka]
Update [tmco]
Review [inpr]
First [qnco]
Published [ocac]
objectives [inpr]
To [qlco]
Assess [acty]
effects [qlco]
Anticoagulant Drugs [phsu]
Heparin [bacs, carb, phsu]
Heparin, Low-Molecular-Weight [carb, phsu]
Anticoagulants, Oral [orch, phsu]
Patients [podg]
Intermittent Claudication [dsyn]
Stage II [inpr]
Improving [qlco]
Walking [dora]
Capacity [qnco]
Pain-Free [orch]
Walking distance [fndg]
Absolute [qlco]
Walking distance [fndg]
Mortality [qnco]
cardiovascular events [fndg]
Ankle brachial pressure index [clna]
progression [patf]
Surgery [bmod]
Amputation [topp]
free [ftcn]
Survival [acty]
side effects [ftcn]
Drugs [phsu]
search [inpr]
Methods [inpr]
Update [tmco]
Peripheral Vascular Diseases [dsyn]
Group [idcn]
Trial [resa]
search [inpr]
Searched [acty]
specialised [qlco]
Last [qlco]
Searched [acty]
Central [spco]
Issue [fndg]
Selection Criteria [qlco]
Trial [resa]
Anticoagulants [phsu]
To [qlco]
TREAT [ftcn]
Patients [podg]
Intermittent Claudication [dsyn]
Data Collection [resa]
Analysis [lbpr]
Seven [qnco]
Study [mnob]
included [ftcn]
Only [qnco]
Three [qnco]
studies [lbpr]
Two [qnco]
Evaluate [ftcn]
Anticoagulants, Oral [orch, phsu]
One [qnco]
Evaluate [ftcn]
Heparin [bacs, carb, phsu]
Meet [idcn]
High [qlco]
Quality [qlco]
methodology [inpr]
Inclusion Criteria [qlco]
included [ftcn]
Primary [qlco]
Analysis [lbpr]
Four [qnco]
studies [lbpr]
included [ftcn]
Sensitivity [qnco]
Analysis [lbpr]
Authors [prog]
Extracted [topp]
Data [idcn]
Main [qlco]
Result [ftcn]
New [tmco]
studies [lbpr]
included [ftcn]
Update [tmco]
Seven [qnco]
Study [mnob]
Combined [qlco]
participants [popg]
included [ftcn]
Review [inpr]
Observed [ftcn]
Heparin [bacs, carb, phsu]
treatment [ftcn]
Control Groups [grup]
Pain-Free [orch]
Walking distance [fndg]
Maximum [qnco]
Walking distance [fndg]
End [spco]
treatment [ftcn]
Data [idcn]
LMWH [carb, phsu]
Benefit [qnco]
Walking distance [fndg]
Revascularisation [topp]
Amputation [topp]
free [ftcn]
Survival Rates [qnco]
Reported [inpr]
One [qnco]
Study [mnob]
Only [qnco]
Five [qnco]
Follow-up [fndg]
Study [mnob]
Reported [inpr]
Effect [qlco]
Overall [inpr]
Mortality [qnco]
cardiovascular events [fndg]
Pooled [cnce]
Odds Ratios [qnco]
Not significant [fndg]
Outcome [ftcn]
Major [qlco]
Minor [popg]
Bleeding [patf]
Events [evnt]
Frequent [tmco]
Group [idcn]
treated [topp]
Anticoagulants, Oral [orch, phsu]
Compared [acty]
To [qlco]
Control [grup]
Increase [ftcn]
Fatal [qlco]
Bleeding [patf]
Events [evnt]
Major [qlco]
Bleeding [patf]
Events [evnt]
Reported [inpr]
Study [mnob]
Evaluate [ftcn]
Heparin [bacs, carb, phsu]
Increase [ftcn]
Minor [popg]
Bleeding [patf]
Events [evnt]
Reported [inpr]
Authors [prog]
Conclusions [idcn]
Benefit [qnco]
Heparin [bacs, carb, phsu]
LMWH [carb, phsu]
Anticoagulants, Oral [orch, phsu]
treatment [ftcn]
Intermittent Claudication [dsyn]
Not [ftcn]
Established [qlco]
Increased [qnco]
Risk [qlco]
Major [qlco]
Bleeding [patf]
Events [evnt]
Observed [ftcn]
Anticoagulants, Oral [orch, phsu]
Clear [qlco]
Evidence [ftcn]
Support [medd]
Anticoagulants [phsu]
Intermittent Claudication [dsyn]
Stage [tmco]
